What is the price-to-earnings ratio of Bridge Biotherapeutics?
The price-earnings ratio of Bridge Biotherapeutics is currently -3.97.
Bridge Biotherapeutics P/E 2024
Bridge Biotherapeutics P/E
-3.97
Ticker
288330.KQ
ISIN
KR7288330004
As of Sep 19, 2024, Bridge Biotherapeutics's P/E ratio was -3.97, a -25.09% change from the -5.3 P/E ratio recorded in the previous year.
The Bridge Biotherapeutics P/E history
Bridge Biotherapeutics Aktienanalyse
What does Bridge Biotherapeutics do?
Bridge Biotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Bridge Biotherapeutics's P/E Ratio
The Price to Earnings (P/E) Ratio of Bridge Biotherapeutics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Bridge Biotherapeutics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Bridge Biotherapeutics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Bridge Biotherapeutics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Bridge Biotherapeutics stock
How has the price-earnings ratio of Bridge Biotherapeutics changed compared to last year?
The price-to-earnings ratio of Bridge Biotherapeutics has increased by -25.09% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Bridge Biotherapeutics high compared to other companies?
Yes, the price-to-earnings ratio of Bridge Biotherapeutics is high compared to other companies.
How does an increase in the price-earnings ratio of Bridge Biotherapeutics affect the company?
An increase in the price-earnings ratio of Bridge Biotherapeutics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Bridge Biotherapeutics affect the company?
A decrease in the price-earnings ratio of Bridge Biotherapeutics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Bridge Biotherapeutics?
Some factors that influence the price-earnings ratio of Bridge Biotherapeutics are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Bridge Biotherapeutics pay?
Over the past 12 months, Bridge Biotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bridge Biotherapeutics is expected to pay a dividend of 0 KRW.
What is the dividend yield of Bridge Biotherapeutics?
The current dividend yield of Bridge Biotherapeutics is .
When does Bridge Biotherapeutics pay dividends?
Bridge Biotherapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bridge Biotherapeutics?
Bridge Biotherapeutics paid dividends every year for the past 0 years.
What is the dividend of Bridge Biotherapeutics?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bridge Biotherapeutics located?
Bridge Biotherapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bridge Biotherapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bridge Biotherapeutics from 9/19/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Bridge Biotherapeutics pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Bridge Biotherapeutics in the year 2023?
In the year 2023, Bridge Biotherapeutics distributed 0 KRW as dividends.
In which currency does Bridge Biotherapeutics pay out the dividend?
The dividends of Bridge Biotherapeutics are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bridge Biotherapeutics
Our stock analysis for Bridge Biotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bridge Biotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Bridge Biotherapeutics Revenue
- Bridge Biotherapeutics Net Income
- Bridge Biotherapeutics P/E
- Bridge Biotherapeutics P/S
- Bridge Biotherapeutics EBIT
- Bridge Biotherapeutics Dividend
- Bridge Biotherapeutics Stocks
- Bridge Biotherapeutics Market capitalization
- Bridge Biotherapeutics Debt
- Bridge Biotherapeutics Liabilities
- Bridge Biotherapeutics Equity
- Bridge Biotherapeutics AAQS
- Bridge Biotherapeutics Employees
- Bridge Biotherapeutics ROE
- Bridge Biotherapeutics ROA
- Bridge Biotherapeutics ROCE